Wu H - Search Results

1

CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challenges.

Hu Y, Tan Su Yin E, Yang Y, Wu H, Wei G, Su J, Cui Q, Jin A, Yang L, Fu S, Zhou J, Qiu L, Zhang X, Liang A, Jing H, Li Y, Blaise D, Mohty M, Nagler A, Huang H. Hu Y, et al. Among authors: wu h. Curr Res Transl Med. 2020 Aug;68(3):111-118. doi: 10.1016/j.retram.2020.06.003. Epub 2020 Jun 28. Curr Res Transl Med. 2020. PMID: 32620465 Free PMC article. Review.

2

Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma.

Huang H, Wu HW, Hu YX. Huang H, et al. Among authors: wu hw. J Zhejiang Univ Sci B. 2020 Jan.;21(1):29-41. doi: 10.1631/jzus.B1900351. J Zhejiang Univ Sci B. 2020. PMID: 31898440 Free PMC article. Review.

3

Ruxolitinib combined with etanercept induce a rapid response to corticosteroid-refractory severe acute graft vs host disease after allogeneic stem cell transplantation: Results of a multi-center prospective study.

Zhao Y, Wu H, Shi J, Luo Y, Li X, Lan J, Ni W, Lu Y, Chen L, Tan Y, Lai X, Yu J, Huang H. Zhao Y, et al. Among authors: wu h. Am J Hematol. 2020 Sep;95(9):1075-1084. doi: 10.1002/ajh.25898. Epub 2020 Jul 6. Am J Hematol. 2020. PMID: 32510625 Free article. Clinical Trial.

4

Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.

Wu H, Shi J, Luo Y, Tan Y, Zhang M, Lai X, Yu J, Liu L, Fu H, Huang H, Zhao Y. Wu H, et al. JAMA Netw Open. 2021 Jan 4;4(1):e2034750. doi: 10.1001/jamanetworkopen.2020.34750. JAMA Netw Open. 2021. PMID: 33502484 Free PMC article.

5

Blinatumomab for HLA loss relapse after haploidentical hematopoietic stem cell transplantation.

Wu H, Cai Z, Shi J, Luo Y, Huang H, Zhao Y. Wu H, et al. Am J Cancer Res. 2021 Jun 15;11(6):3111-3122. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249448 Free PMC article.

6

COVID-19 in Hematologic Malignancies: Big Challenges.

Hu Y, Wang L, Cui Q, Su Yin ET, Wu H, Nagler A, Huang H. Hu Y, et al. Among authors: wu h. Clin Hematol Int. 2020 Oct 7;2(4):173-175. doi: 10.2991/chi.k.200919.001. eCollection 2020 Dec. Clin Hematol Int. 2020. PMID: 34595459 Free PMC article. No abstract available.

7

Assessment of Patient-Specific Human Leukocyte Antigen Genomic Loss at Relapse After Antithymocyte Globulin-Based T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplant.

Wu H, Shi J, Luo Y, Yu J, Lai X, Liu L, Fu H, Ouyang G, Xu X, Xiao H, Huang H, Zhao Y. Wu H, et al. JAMA Netw Open. 2022 Apr 1;5(4):e226114. doi: 10.1001/jamanetworkopen.2022.6114. JAMA Netw Open. 2022. PMID: 35385089 Free PMC article.

8

Prognostic factors and clinical outcomes in patients with relapsed acute leukemia after allogeneic hematopoietic stem cell transplantation.

Gao Y, Wu H, Shi Z, Gao F, Shi J, Luo Y, Yu J, Lai X, Fu H, Liu L, Huang H, Zhao Y. Gao Y, et al. Among authors: wu h. Bone Marrow Transplant. 2023 Aug;58(8):863-873. doi: 10.1038/s41409-023-01989-3. Epub 2023 Apr 29. Bone Marrow Transplant. 2023. PMID: 37120616

9

Haploidentical transplants deliver equal outcomes to matched sibling transplants: a propensity score-matched analysis.

Wu H, Zhao Y, Gao F, Shi J, Luo Y, Yu J, Lai X, Liu L, Fu H, Qian P, Huang H, Zhao Y. Wu H, et al. J Transl Med. 2023 May 18;21(1):329. doi: 10.1186/s12967-023-04168-6. J Transl Med. 2023. PMID: 37198603 Free PMC article.

10

Altered intestinal microbiome and epithelial damage aggravate intestinal graft-versus-host disease.

Gao F, Wu H, Wang L, Zhao Y, Huang H. Gao F, et al. Among authors: wu h. Gut Microbes. 2023 Jan-Dec;15(1):2221821. doi: 10.1080/19490976.2023.2221821. Gut Microbes. 2023. PMID: 37305973 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44,046 results

Search Page